enVVeno Medical (NVNO) Assets Average (2018 - 2026)

enVVeno Medical's Assets Average history runs 9 years deep, the most recent figure standing at $27.8 million for Q1 2026.

• On a quarterly basis, Assets Average fell 34.93% year-over-year to $27.8 million in Q1 2026; TTM through Mar 2026 was $27.8 million, a 34.93% decrease from a year earlier, with the FY2025 full-year figure at $37.3 million, down 20.38% from the prior year.
• Assets Average slipped to $27.8 million in Q1 2026 per NVNO's latest filing, from $31.0 million in the prior quarter.
• Across five years, Assets Average topped out at $56.0 million in Q1 2022 and bottomed at $27.8 million in Q1 2026.
• The 5-year median for Assets Average is $42.8 million (2025), against an average of $41.1 million.
• Across the five-year window, Assets Average jumped 101.33% in 2022 and tumbled 36.91% in 2023, its largest moves.
• Year by year, Assets Average stood at $43.6 million in 2022, then fell by 11.92% to $38.4 million in 2023, then grew by 24.26% to $47.7 million in 2024, then sank by 35.06% to $31.0 million in 2025, then dropped by 10.1% to $27.8 million in 2026.
• Per Business Quant, the three latest NVNO Assets Average figures stand at $27.8 million (Q1 2026), $31.0 million (Q4 2025), and $34.5 million (Q3 2025).